InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
surf1944 Free
08/20/08 10:46 AM
profile icon
surf1944 Free
06/25/08 4:23 PM
profile icon
surf1944 Free
06/24/08 8:11 AM
profile icon
surf1944 Free
05/23/08 10:20 AM
profile icon
surf1944 Free
05/07/08 4:59 PM
profile icon
surf1944 Free
04/29/08 10:43 AM
profile icon
surf1944 Free
04/23/08 7:46 AM
profile icon
surf1944 Free
04/03/08 12:41 PM
profile icon
surf1944 Free
03/04/08 10:16 PM
profile icon
surf1944 Free
02/26/08 4:51 PM
profile icon
surf1944 Free
02/21/08 12:12 PM
profile icon
mlkrborn Free
02/21/08 12:07 PM
profile icon
surf1944 Free
02/21/08 12:06 PM
profile icon
mlkrborn Free
02/21/08 11:59 AM
profile icon
mlkrborn Free
02/21/08 11:58 AM
profile icon
surf1944 Free
02/06/08 9:18 PM
profile icon
surf1944 Free
01/28/08 3:43 PM
profile icon
surf1944 Free
12/10/07 4:20 PM
profile icon
surf1944 Free
12/05/07 7:27 PM
profile icon
surf1944 Free
10/30/07 10:30 PM
profile icon
surf1944 Free
10/29/07 11:13 PM
profile icon
surf1944 Free
09/25/07 10:18 PM
profile icon
surf1944 Free
09/19/07 10:19 PM
profile icon
surf1944 Free
09/19/07 12:57 PM
profile icon
surf1944 Free
09/19/07 12:55 PM
profile icon
surf1944 Free
09/17/07 11:18 AM
profile icon
surf1944 Free
09/17/07 10:49 AM
profile icon
surf1944 Free
09/14/07 2:58 PM
profile icon
mlkrborn Free
09/14/07 2:38 PM
profile icon
surf1944 Free
08/28/07 11:32 PM
profile icon
surf1944 Free
08/21/07 7:02 PM
profile icon
surf1944 Free
08/20/07 10:27 PM
profile icon
surf1944 Free
08/12/07 3:50 PM
profile icon
apostrophe Free
02/27/07 1:27 PM
profile icon
apostrophe Free
02/07/07 1:23 PM
profile icon
apostrophe Free
02/07/07 2:33 AM
profile icon
apostrophe Free
02/06/07 1:51 PM

Replidyne (RDYN) RSS Feed

Followers
1
Posters
3
Posts (Today)
0
Posts (Total)
38
Created
02/06/07
Type
Free
Moderators
http://www.replidyne.com/index.cfm?fuseaction=home http://finance.yahoo.com/q/ks?s=RDYN http://moneycentral.msn.com/ownership?Symbol=RDYN http://www.mffais.com/rdyn.html Replidyne Provides Strategic Update Dec 2007 http://ir.replidyne.com/phoenix.zhtml?c=189384&p=irol-newsArticle&ID=1085843 Replidyne, Inc., a biopharmaceutical company, focuses on discovering, developing, in-licensing, and commercializing anti-infective products. Its products include Faropenem Medoxomil, an oral antibiotic; and REP8839, an anti-infective product, which is in Phase I clinical development for the treatment of skin and wound infections comprising methicillin resistant Staphylococcus aureus. The company's various forms of faropenem medoxomil include Oral liquid formulation, which has completed Phase II clinical trial for acute otitis media; 300 mg tablet that has completed Phase III clinical trial for acute bacterial sinusitis; and 600 mg tablet, which is in Phase III clinical trial for acute exacerbation of chronic bronchitis. The company also develops assays that identify compounds that inhibit bacterial DNA replication; and products to treat infections in hospital settings caused by Clostridium difficile. It has license agreement with Daiichi Asubio Pharma Co., Ltd. to develop and commercialize various forms of faropenem medoxomil for adult and pediatric use in the United States and Canada. The company was founded in 2000 and is headquartered in Louisville, Colorado.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
RDYN Latest News
  • No Recent News Available for this company!
New Post